101
|
Greco R, Mancini N, Peccatori J, Cieri N, Vago L, Giglio F, Morelli M, Ghidoli N, Carletti S, Levati G, Crucitti L, Sala E, Lupo Stanghellini MT, Lorentino F, Forcina A, Pavesi F, Carrabba M, Marktel S, Assanelli A, Marcatti M, Bernardi M, Corti C, Doglioni C, Scarpellini P, Burioni R, Bonini C, Clementi M, Ciceri F. Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia. Heart Lung Vessel 2014; 6:119-124. [PMID: 25024994 PMCID: PMC4095839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Diagnosis of invasive fungal infection remains challenging. Here we report a case of early diagnosis of invasive aspergillosis in a neutropenic patient affected by acute myeloid leukaemia, achieved through the detection of Aspergillus fumigatus species-specific ribonucleic acid sequences by a sensitive multiplex real-time polymerase chain reaction-based molecular assay. Thanks to the early diagnosis, targeted therapy was promptly established and the severe fungal infection controlled, allowing the patient to subsequently receive allogeneic hematopoietic stem cell transplantation from a haploidentical donor, her only curative option. Also in this instance, targeted secondary antifungal prophylaxis with voriconazole avoided any other fungal infection afterwards. This report suggests how the implementation of molecular assays in combination with routine diagnostic procedures, can improve microbiological diagnosis in sepsis, particularly in case of fungal infection, difficult to detect with standard microbiological culture methods.
Collapse
Affiliation(s)
- R Greco
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - N Mancini
- Laboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - J Peccatori
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - N Cieri
- Experimental Hematology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - L Vago
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - F Giglio
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - M Morelli
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - N Ghidoli
- Laboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - S Carletti
- Laboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - G Levati
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - L Crucitti
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - E Sala
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - M T Lupo Stanghellini
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - F Lorentino
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - A Forcina
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - F Pavesi
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - M Carrabba
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - S Marktel
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - A Assanelli
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - M Marcatti
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - M Bernardi
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - C Corti
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - C Doglioni
- Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - P Scarpellini
- Infectious Disease Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - R Burioni
- Laboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - C Bonini
- Experimental Hematology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - M Clementi
- Laboratory of Microbiology and Virology, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - F Ciceri
- Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
| |
Collapse
|
102
|
Criscuolo E, Cappelletti F, Sautto G, Diotti R, Clementi N, Mancini N, Clementi M, Burioni R. Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome. Clin Biochem 2013. [DOI: 10.1016/j.clinbiochem.2013.05.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
103
|
Dvir R, Mancini N, Assanelli A, Racca S, Rolla S, Clementi N, Piemontese S, Ciceri F, Burioni R, Clementi M. Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation. J Clin Virol 2013; 57:1-4. [DOI: 10.1016/j.jcv.2012.11.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2012] [Revised: 11/12/2012] [Accepted: 11/19/2012] [Indexed: 10/27/2022]
|
104
|
Abstract
Prions are infectious proteins that are responsible for transmissible spongiform encephalopathies (TSEs) and consist primarily of scrapie prion protein (PrPSc), a pathogenic isoform of the host-encoded cellular prion protein (PrPC). The absence of nucleic acids as essential components of the infectious prions is the most striking feature associated to these diseases. Additionally, different prion strains have been isolated from animal diseases despite the lack of DNA or RNA molecules. Mounting evidence suggests that prion-strain-specific features segregate with different PrPSc conformational and aggregation states.
Strains are of practical relevance in prion diseases as they can drastically differ in many aspects, such as incubation period, PrPSc biochemical profile (e.g., electrophoretic mobility and glycoform ratio) and distribution of brain lesions. Importantly, such different features are maintained after inoculation of a prion strain into genetically identical hosts and are relatively stable across serial passages.
This review focuses on the characterization of prion strains and on the wide range of important implications that the study of prion strains involves.
Collapse
Affiliation(s)
- Laura Solforosi
- Laboratory of Microbiology and Virology; University Vita-Salute San Raffaele; Milan, Italy.
| | | | | | | | | |
Collapse
|
105
|
Clementi N, Mancini N, Castelli M, Clementi M, Burioni R. Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools. Drug Discov Today 2012. [PMID: 23178804 DOI: 10.1016/j.drudis.2012.11.006] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Monoclonal antibodies (mAbs) have been used successfully both in research and for clinical purposes. The possible use of protective mAbs directed against different microbial pathogens is currently being considered. The fine definition of the epitope recognized by a protective mAb is an important aspect to be considered for possible development in epitope-based vaccinology. The most accurate approach to this is the X-ray resolution of mAb/antigen crystal complex. Unfortunately, this approach is not always feasible. Under this perspective, several surrogate epitope mapping strategies based on the use of bioinformatics have been developed. In this article, we review the most common, freely accessible, bioinformatic tools used for epitope characterization and provide some basic examples of molecular visualization, editing and computational analysis.
Collapse
Affiliation(s)
- Nicola Clementi
- Microbiology and Virology Unit, 'Vita-Salute San Raffaele' University, 20132 Milan, Italy.
| | | | | | | | | |
Collapse
|
106
|
Clementi N, Criscuolo E, Castelli M, Mancini N, Clementi M, Burioni R. Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines. Viruses 2012; 4:3090-108. [PMID: 23202517 PMCID: PMC3509685 DOI: 10.3390/v4113090] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2012] [Revised: 11/05/2012] [Accepted: 11/07/2012] [Indexed: 01/03/2023] Open
Abstract
The emergence of new influenza strains causing pandemics represents a serious threat to human health. From 1918, four influenza pandemics occurred, caused by H1N1, H2N2 and H3N2 subtypes. Moreover, in 1997 a novel influenza avian strain belonging to the H5N1 subtype infected humans. Nowadays, even if its transmission is still circumscribed to avian species, the capability of the virus to infect humans directly from avian reservoirs can result in fatalities. Moreover, the risk that this or novel avian strains could adapt to inter-human transmission, the development of resistance to anti-viral drugs and the lack of an effective prevention are all incumbent problems for the world population. In this scenario, the identification of broadly neutralizing monoclonal antibodies (mAbs) directed against conserved regions shared among influenza isolates has raised hopes for the development of monoclonal antibody-based immunotherapy and "universal" anti-influenza vaccines.
Collapse
MESH Headings
- Animals
- Antibodies, Monoclonal/immunology
- Antibodies, Neutralizing/immunology
- Antigens, Viral/chemistry
- Antigens, Viral/immunology
- B-Lymphocytes/immunology
- Cross Reactions/immunology
- Epitopes, B-Lymphocyte/chemistry
- Epitopes, B-Lymphocyte/immunology
- Hemagglutinin Glycoproteins, Influenza Virus/chemistry
- Hemagglutinin Glycoproteins, Influenza Virus/immunology
- Humans
- Influenza A virus/classification
- Influenza A virus/genetics
- Influenza A virus/immunology
- Influenza Vaccines/immunology
- Influenza, Human/immunology
- Influenza, Human/prevention & control
Collapse
Affiliation(s)
- Nicola Clementi
- Microbiology and Virology Unit, Vita-Salute San Raffaele University, Milan 20132, Italy.
| | | | | | | | | | | |
Collapse
|
107
|
Diotti RA, Sautto GA, Solforosi L, Mancini N, Clementi M, Burioni R. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein. New Microbiol 2012; 35:475-479. [PMID: 23109015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 08/02/2012] [Accepted: 09/05/2012] [Indexed: 06/01/2023]
Abstract
Hepatitis C virus (HCV) is the major cause of chronic liver disease worldwide. There is evidence that neutralizing anti-HCV antibodies may find potential applications in novel prophylactic and therapeutic strategies. This paper describes the very high neutralization activity and unique biological features of two broadly cross-reactive and cross-neutralizing anti-HCV human monoclonal IgG1 derived from human monoclonal recombinant Fab fragments.
Collapse
Affiliation(s)
- Roberta Antonia Diotti
- Laboratory of Microbiology and Virology, Universita Vita-Salute San Raffaele, Milano, Italy.
| | | | | | | | | | | |
Collapse
|
108
|
Sautto G, Mancini N, Diotti RA, Solforosi L, Clementi M, Burioni R. Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference. Antiviral Res 2012; 96:82-9. [PMID: 22898087 DOI: 10.1016/j.antiviral.2012.07.013] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2012] [Revised: 07/27/2012] [Accepted: 07/30/2012] [Indexed: 01/06/2023]
Abstract
The suggested HCV escape mechanism consisting in the elicitation of antibody (Ab) subpopulations interfering with the neutralizing activity of other Abs has recently been questioned. In particular, it was originally reported that Abs directed against the 436-447 region (epitope II) of HCV/E2 glycoprotein may interfere with the neutralizing Abs directed against the 412-423 region (epitope I) involved in the binding to CD81. In this paper, we investigate on the molecular features of this phenomenon describing an anti-HCV/E2 monoclonal Ab (mAb) (e509) endowed with a weak neutralizing activity, and whose epitope is centered on epitope II. Interestingly, e509 influenced the potent neutralizing activity of AP33, one of the best characterized anti-HCV/E2 mAb, whereas it did not show any interfering activity against two other broadly neutralizing mAbs (e20 and e137), whose epitopes partially overlap with that of e509 and which possibly displace it from the antigen. These data may give a possible clue to interpret the conflicting studies published to date on the mechanism of interference, suggesting the existence of at least two groups of broadly neutralizing anti-HCV/E2 Abs: (i) those whose epitope is focused on the 412-423 CD81-binding region and whose activity may be hampered by other Abs directed against the 436-447 region, and (ii) those directed against CD81-binding regions but whose epitope contains also residues within the 436-447 region recognized by interfering mAbs, thus competing with them for binding. The conflicting results of previous studies may therefore depend on the relative amount of each of these two populations in the polyclonal preparations used. Overall, a better comprehension of this phenomenon may be of importance in the set up of novel mAb-based anti-HCV therapeutic strategies.
Collapse
Affiliation(s)
- Giuseppe Sautto
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italy
| | | | | | | | | | | |
Collapse
|
109
|
Clementi N, Mancini N, Solforosi L, Castelli M, Clementi M, Burioni R. Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens. Int J Mol Sci 2012; 13:8273-8292. [PMID: 22942702 PMCID: PMC3430233 DOI: 10.3390/ijms13078273] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2012] [Revised: 06/25/2012] [Accepted: 06/27/2012] [Indexed: 11/16/2022] Open
Abstract
In the last two decades, several phage display-selected monoclonal antibodies (mAbs) have been described in the literature and a few of them have managed to reach the clinics. Among these, the anti-respiratory syncytial virus (RSV) Palivizumab, a phage-display optimized mAb, is the only marketed mAb directed against microbial pathogens. Palivizumab is a clear example of the importance of choosing the most appropriate strategy when selecting or optimizing an anti-infectious mAb. From this perspective, the extreme versatility of phage-display technology makes it a useful tool when setting up different strategies for the selection of mAbs directed against human pathogens, especially when their possible clinical use is considered. In this paper, we review the principal phage display strategies used to select anti-infectious mAbs, with particular attention focused on those used against hypervariable pathogens, such as HCV and influenza viruses.
Collapse
Affiliation(s)
- Nicola Clementi
- Author to whom correspondence should be addressed; E-Mail: ; Tel.: +39-2-2643-5082; Fax: +39-2-2643-4288
| | | | | | | | | | | |
Collapse
|
110
|
Solforosi L, Mancini N, Canducci F, Clementi N, Sautto GA, Diotti RA, Clementi M, Burioni R. A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments. New Microbiol 2012; 35:289-294. [PMID: 22842598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 06/18/2012] [Accepted: 07/02/2012] [Indexed: 06/01/2023]
Abstract
A novel phagemid vector, named pCM, was optimized for the cloning and display of antibody fragment (Fab) libraries on the surface of filamentous phage. This vector contains two long DNA "stuffer" fragments for easier differentiation of the correctly cut forms of the vector. Moreover, in pCM the fragment at the heavy-chain cloning site contains an acid phosphatase-encoding gene allowing an easy distinction of the Escherichia coli cells containing the unmodified form of the phagemid versus the heavy-chain fragment coding cDNA. In pCM transcription of heavy-chain Fd/gene III and light chain is driven by a single lacZ promoter. The light chain is directed to the periplasm by the ompA signal peptide, whereas the heavy-chain Fd/coat protein III is trafficked by the pelB signal peptide. The phagemid pCM was used to generate a human combinatorial phage display antibody library that allowed the selection of a monoclonal Fab fragment antibody directed against the nucleoprotein (NP) of Influenza A virus.
Collapse
Affiliation(s)
- Laura Solforosi
- Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy
| | | | | | | | | | | | | | | |
Collapse
|
111
|
Mancini N, Poloniato A, Ghidoli N, Carletti S, Fomasi M, Barera G, Rovelli R, Cichero P, Burioni R, Clementi M. Potential role of the detection of enterobacterial DNA in blood for the management of neonatal necrotizing enterocolitis. J Med Microbiol 2012; 61:1465-1472. [PMID: 22700552 DOI: 10.1099/jmm.0.043067-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
We present three cases of pre-term low-weight infants with suspected necrotizing enterocolitis (NEC) [one eventually recognized as a connatal cytomegalovirus (CMV) infection], microbiologically monitored using a molecular assay detecting bacterial and fungal DNA in blood. The detection of DNA from enteric pathogens in blood was interpreted as a sign of ongoing perforation, and represented a useful complement in the management of the presented cases. Moreover, these cases suggest the opportunity for larger future studies to assess the possible role of a molecular approach in the close monitoring of infants with suspected NEC or with other conditions at-risk for intestinal perforation.
Collapse
Affiliation(s)
- Nicasio Mancini
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Antonella Poloniato
- U.O. di Neonatologia e Patologia Neonatale, Dipartimento di Pediatria, Ospedale San Raffaele, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Nadia Ghidoli
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Silvia Carletti
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Martina Fomasi
- U.O. di Neonatologia e Patologia Neonatale, Dipartimento di Pediatria, Ospedale San Raffaele, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Graziano Barera
- U.O. di Neonatologia e Patologia Neonatale, Dipartimento di Pediatria, Ospedale San Raffaele, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Rosanna Rovelli
- U.O. di Neonatologia e Patologia Neonatale, Dipartimento di Pediatria, Ospedale San Raffaele, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Paola Cichero
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Roberto Burioni
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Massimo Clementi
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| |
Collapse
|
112
|
De Marco D, Clementi N, Mancini N, Solforosi L, Moreno GJ, Sun X, Tumpey TM, Gubareva LV, Mishin V, Clementi M, Burioni R. A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. PLoS One 2012; 7:e34415. [PMID: 22496802 PMCID: PMC3319592 DOI: 10.1371/journal.pone.0034415] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2011] [Accepted: 02/27/2012] [Indexed: 11/21/2022] Open
Abstract
Influenza viruses are among the most important human pathogens and are responsible for annual epidemics and sporadic, potentially devastating pandemics. The humoral immune response plays an important role in the defense against these viruses, providing protection mainly by producing antibodies directed against the hemagglutinin (HA) glycoprotein. However, their high genetic variability allows the virus to evade the host immune response and the potential protection offered by seasonal vaccines. The emergence of resistance to antiviral drugs in recent years further limits the options available for the control of influenza. The development of alternative strategies for influenza prophylaxis and therapy is therefore urgently needed. In this study, we describe a human monoclonal antibody (PN-SIA49) that recognizes a highly conserved epitope located on the stem region of the HA and able to neutralize a broad spectrum of influenza viruses belonging to different subtypes (H1, H2 and H5). Furthermore, we describe its protective activity in mice after lethal challenge with H1N1 and H5N1 viruses suggesting a potential application in the treatment of influenza virus infections.
Collapse
MESH Headings
- Amino Acid Sequence
- Animals
- Antibodies, Monoclonal/immunology
- Antibodies, Monoclonal/therapeutic use
- Antibodies, Viral/immunology
- Epitopes/genetics
- Epitopes/immunology
- Female
- Hemagglutinin Glycoproteins, Influenza Virus/chemistry
- Hemagglutinin Glycoproteins, Influenza Virus/immunology
- Hemagglutinin Glycoproteins, Influenza Virus/metabolism
- Hemagglutinins/genetics
- Hemagglutinins/immunology
- Hemagglutinins/metabolism
- Humans
- Influenza A Virus, H1N1 Subtype/genetics
- Influenza A Virus, H1N1 Subtype/immunology
- Influenza A Virus, H5N1 Subtype/genetics
- Influenza A Virus, H5N1 Subtype/immunology
- Influenza Vaccines/immunology
- Influenza Vaccines/therapeutic use
- Mice
- Mice, Inbred BALB C
- Molecular Sequence Data
- Mutagenesis
- Mutation/genetics
- Neutralization Tests
- Orthomyxoviridae Infections/immunology
- Orthomyxoviridae Infections/prevention & control
- Orthomyxoviridae Infections/virology
- Protein Conformation
- Sequence Homology, Amino Acid
Collapse
Affiliation(s)
- Donata De Marco
- Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy
| | - Nicola Clementi
- Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy
| | - Nicasio Mancini
- Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy
| | - Laura Solforosi
- Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy
| | - Guisella J. Moreno
- Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy
| | - Xiangjie Sun
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
| | - Terrence M. Tumpey
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
| | - Larisa V. Gubareva
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
| | - Vasiliy Mishin
- Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
| | - Massimo Clementi
- Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy
| | - Roberto Burioni
- Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy
- * E-mail:
| |
Collapse
|
113
|
Clementi N, De Marco D, Mancini N, Solforosi L, Moreno GJ, Gubareva LV, Mishin V, Di Pietro A, Vicenzi E, Siccardi AG, Clementi M, Burioni R. A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. PLoS One 2011; 6:e28001. [PMID: 22162996 PMCID: PMC3230632 DOI: 10.1371/journal.pone.0028001] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2011] [Accepted: 10/30/2011] [Indexed: 12/21/2022] Open
Abstract
The interest in broad-range anti-influenza A monoclonal antibodies (mAbs) has recently been strengthened by the identification of anti-hemagglutinin (HA) mAbs endowed with heterosubtypic neutralizing activity to be used in the design of "universal" prophylactic or therapeutic tools. However, the majority of the single mAbs described to date do not bind and neutralize viral isolates belonging to highly divergent subtypes clustering into the two different HA-based influenza phylogenetic groups: the group 1 including, among others, subtypes H1, H2, H5 and H9 and the group 2 including, among others, H3 subtype. Here, we describe a human mAb, named PN-SIA28, capable of binding and neutralizing all tested isolates belonging to phylogenetic group 1, including H1N1, H2N2, H5N1 and H9N2 subtypes and several isolates belonging to group 2, including H3N2 isolates from the first period of the 1968 pandemic. Therefore, PN-SIA28 is capable of neutralizing isolates belonging to subtypes responsible of all the reported pandemics, as well as other subtypes with pandemic potential. The region recognized by PN-SIA28 has been identified on the stem region of HA and includes residues highly conserved among the different influenza subtypes. A deep characterization of PN-SIA28 features may represent a useful help in the improvement of available anti-influenza therapeutic strategies and can provide new tools for the development of universal vaccinal strategies.
Collapse
Affiliation(s)
- Nicola Clementi
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italia
| | - Donata De Marco
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italia
| | - Nicasio Mancini
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italia
| | - Laura Solforosi
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italia
| | - Guisella J. Moreno
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italia
| | - Larisa V. Gubareva
- Virus Surveillance and Diagnosis Branch, Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
| | - Vasiliy Mishin
- Virus Surveillance and Diagnosis Branch, Influenza Division, NCIRD, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
| | - Andrea Di Pietro
- Viral Pathogens and Biosafety Unit, Divisione di Immunologia, Trapianti e Malattie infettive, Istituto Scientifico San Raffaele, Milano, Italia
| | - Elisa Vicenzi
- Viral Pathogens and Biosafety Unit, Divisione di Immunologia, Trapianti e Malattie infettive, Istituto Scientifico San Raffaele, Milano, Italia
| | - Antonio G. Siccardi
- Istituto Scientifico San Raffaele, Milano, Italia
- Dipartimento di Biologia e Genetica per le Scienze Mediche, Università di Milano, Milano, Italia
| | - Massimo Clementi
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italia
| | - Roberto Burioni
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italia
- * E-mail:
| |
Collapse
|
114
|
Mancini N, Solforosi L, Clementi N, De Marco D, Clementi M, Burioni R. A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza. Antiviral Res 2011; 92:15-26. [DOI: 10.1016/j.antiviral.2011.07.013] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2011] [Revised: 05/19/2011] [Accepted: 07/12/2011] [Indexed: 10/17/2022]
|
115
|
Mancini N, Diotti RA, Perotti M, Sautto G, Clementi N, Nitti G, Patel AH, Ball JK, Clementi M, Burioni R. Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes. PLoS One 2009; 4:e8254. [PMID: 20011511 PMCID: PMC2785886 DOI: 10.1371/journal.pone.0008254] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2009] [Accepted: 11/18/2009] [Indexed: 12/18/2022] Open
Abstract
Anti-hepatitis C virus (HCV) cross-neutralizing human monoclonal antibodies, directed against conserved epitopes on surface E2 glycoprotein, are central tools for understanding virus-host interplay, and for planning strategies for prevention and treatment of this infection. Recently, we developed a research aimed at identifying these antibody specificities. The characteristics of one of these antibodies (Fab e20) were addressed in this study. Firstly, using immunofluorescence and FACS analysis of cells expressing envelope HCV glycoproteins, Fab e20 was able to recognize all HCV genotypes. Secondly, competition assays with a panel of mouse and rat monoclonals, and alanine scanning mutagenesis analyses located the e20 epitope within the CD81 binding site, documenting that three highly conserved HCV/E2 residues (W529, G530 and D535) are critical for e20 binding. Finally, a strong neutralizing activity against HCV pseudoparticles (HCVpp) incorporating envelope glycoproteins of genotypes 1a, 1b, 2a, 2b and 4, and against the cell culture-grown (HCVcc) JFH1 strain, was observed. The data highlight that neutralizing antibodies against HCV epitopes present in all HCV genotypes are elicited during natural infection. Their availability may open new avenues to the understanding of HCV persistence and to the development of strategies for the immune control of this infection.
Collapse
Affiliation(s)
- Nicasio Mancini
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italia.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
116
|
Burioni R, Canducci F, Mancini N, Clementi N, Sassi M, De Marco D, Saita D, Diotti RA, Sautto G, Sampaolo M, Clementi M. Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV). New Microbiol 2009; 32:319-324. [PMID: 20128437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The pandemic caused by the new H1N1 swine-origin influenza virus (S-OIV) strain is a worldwide health emergency and alternative therapeutic and prophylactic options are greatly needed. Two human monoclonal antibody Fab fragments (HMab) neutralizing the novel H1N1 influenza strain at very low concentrations were cloned from a patient who had a broad-range anti-H1N1 serum neutralizing activity. The two HMabs neutralized S-OIV with an IC50 of 2.8 and 4 microg/mL. The genes coding for the neutralizing HMabs could be used for generating full human monoclonal IgGs that can be safely administered with the potentially of representing a novel drug to be used in the prophylaxis and the treatment of this human infection. This is the first report of molecular cloning of human monoclonal antibodies against the new pandemic swine-origin influenza virus.
Collapse
MESH Headings
- Animals
- Antibodies, Monoclonal/genetics
- Antibodies, Monoclonal/immunology
- Antibodies, Monoclonal/therapeutic use
- Antibodies, Neutralizing/genetics
- Antibodies, Neutralizing/immunology
- Antibodies, Neutralizing/therapeutic use
- Antibodies, Viral/genetics
- Antibodies, Viral/immunology
- Antibodies, Viral/therapeutic use
- Cell Line
- Cloning, Molecular/methods
- Disease Outbreaks
- Humans
- Immunoglobulin Fab Fragments/genetics
- Immunoglobulin Fab Fragments/immunology
- Immunoglobulin G/genetics
- Immunoglobulin G/immunology
- Immunoglobulin G/therapeutic use
- Influenza A Virus, H1N1 Subtype/immunology
- Influenza, Human/immunology
- Influenza, Human/prevention & control
- Influenza, Human/virology
- Middle Aged
- Orthomyxoviridae Infections/immunology
- Orthomyxoviridae Infections/prevention & control
- Orthomyxoviridae Infections/virology
- Swine
- Swine Diseases/immunology
- Swine Diseases/prevention & control
- Swine Diseases/virology
Collapse
Affiliation(s)
- Roberto Burioni
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
117
|
Burioni R, Canducci F, Saita D, Perotti M, Mancini N, De Marco D, Clementi N, Chieffo A, Denaro M, Cianflone D, Manfredi AA, Colombo A, Maseri A, Clementi M. Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques. J Immunol 2009; 183:2537-44. [PMID: 19635916 DOI: 10.4049/jimmunol.0901076] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Recent data indicated that adaptive immunity is involved in the process of atherogenesis. Oligoclonal recruitment of T lymphocytes has been described in coronary plaques of patients with acute coronary syndrome. However, the nature of immune response remains to be determined. In the present study, we examined the Ab response in six coronary plaques obtained by endoluminal directional atherectomy. The IgG1/kappa-coding gene repertoires of B lymphocytes present in circulating blood and in coronary plaques were cloned and analyzed. In all of the six plaques, we observed 1) a skewed usage of heavy and light IgG1/kappa Ab-coding genes, 2) an oligoclonal distribution of V(K), J(K), and V(H), D(H), and J(H) genes with overrepresentation of some rarely used IgG genes, and 3) the unequivocal signs of Ag-driven clonal expansion and evolution of B cells. The data document for the first time the presence of a local Ag-driven clonal evolution of B cells in human atherosclerotic plaques.
Collapse
|
118
|
Mancini N, Clerici D, Diotti R, Perotti M, Ghidoli N, De Marco D, Pizzorno B, Emrich T, Burioni R, Ciceri F, Clementi M. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. J Med Microbiol 2008; 57:601-604. [PMID: 18436593 DOI: 10.1099/jmm.0.47732-0] [Citation(s) in RCA: 121] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The rapid diagnosis of an infectious cause in the course of fever of unknown origin plays a pivotal role in the correct management of neutropenic patients. In this study, blood samples from febrile oncohaematological patients were tested using a novel commercial real-time PCR assay (LightCycler SeptiFast; Roche Molecular Systems) and blood culture (BacT/Alert 3D; bioMérieux). Twenty-one (20.4 %) and 34 (33 %) of the 103 samples under study tested positive by blood culture and PCR, respectively. The analysis of concordance evidenced a low correlation between the two approaches (83 %), mainly due to samples that tested negative by culture but positive using the molecular approach. Among 14 discordant cases negative by culture but positive by PCR, 12 were observed in sequential samples of patients with initial concordant results on samples drawn before the administration of a specific antimicrobial therapy. Moreover, DNA of a fastidious organism, Aspergillus fumigatus, not easily detectable by the cultural approach was rapidly detected in the two remaining discordant cases. Overall, the characteristics featured by the molecular method could be of interest in the development of new algorithms for the diagnosis of sepsis in critical patients.
Collapse
Affiliation(s)
- Nicasio Mancini
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Daniela Clerici
- Unità di Ematologia e Trapianto di Midollo Osseo, Istituto Scientifico San Raffaele, Milano, Italy
| | - Roberta Diotti
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Mario Perotti
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Nadia Ghidoli
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Donata De Marco
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | | | - Thomas Emrich
- Roche Diagnostics GmbH, Molecular Diagnostics, Penzberg, Germany
| | - Roberto Burioni
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| | - Fabio Ciceri
- Unità di Ematologia e Trapianto di Midollo Osseo, Istituto Scientifico San Raffaele, Milano, Italy
| | - Massimo Clementi
- Laboratorio di Microbiologia e Virologia, Università 'Vita-Salute' San Raffaele, Milano, Italy
| |
Collapse
|
119
|
Perotti M, Ghidoli N, Altara R, Diotti RA, Clementi N, De Marco D, Sassi M, Clementi M, Burioni R, Mancini N. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia. Autoimmun Rev 2008; 7:468-72. [PMID: 18558364 DOI: 10.1016/j.autrev.2008.03.008] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2008] [Accepted: 03/12/2008] [Indexed: 12/13/2022]
Abstract
Hepatitis C virus (HCV) infection has been closely related to mixed cryoglobulinemia (MC). During HCV infection, cryoglobulins derive from the restricted expression of few germline genes as VH1-69, a subfamily highly represented in anti-HCV humoral response. Little is known about the self-reacting IgM component of the cryoprecipitate. In the present study, the IgM/K repertoire of an HCV-infected cryoglobulinemic patient was dissected by phage-display on well-characterized anti-HCV/E2 VH1-69-derived monoclonal IgG1/Kappa Fab fragments cloned from the same patient. All selected IgM clones were shown to react with the anti-HCV/E2 antibodies belonging to VH1-69 subfamily. More than 60% of selected clones showed a bias in VH gene usage, restricted to two VH subfamilies frequently described in autoimmune manifestations (VH3-23; VH3-21). Moreover, all selected clones showed an high similarity (>98.5%) to germline genes evidencing their natural origin. A possible hypothesis is that clones belonging to some subfamilies are naturally prone to react against other VH gene subfamilies, as VH 1-69. An antigen-driven stimulation of these subfamilies, and their overexpression as in HCV infection, could lead to a breaking of humoral homeostatic balance exposing the patients to the risk of developing autoimmune disorders.
Collapse
Affiliation(s)
- Mario Perotti
- Laboratorio di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milan, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
120
|
Moro M, Nizzero P, Biancardi A, Baldan R, Scarpellini P, Curti C, Cichero P, Ossi C, Mancini N, Colombo S, Marazzi M, Mazzuconi R, Cirillo D. An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy. J Hosp Infect 2008; 68:97-9. [DOI: 10.1016/j.jhin.2007.10.007] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2007] [Accepted: 10/12/2007] [Indexed: 12/22/2022]
|
121
|
De Marco D, Perotti M, Ossi CM, Burioni R, Clementi M, Mancini N. Development and validation of a molecular method for the diagnosis of medically important fungal infections. New Microbiol 2007; 30:308-12. [PMID: 17802916] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/17/2023]
Abstract
The increasing incidence of severe fungal infections highlights the need for rapid and precise identification methods in clinical mycology. The aim of this study was to develop and validate a culture-indipendent molecular approach that could allow the detection of fungal pathogens in clinical samples, with particular attention to the identification of drug-resistant Candida and Aspergillus species. A real-time multiplex PCR assay was developed using TaqMan probes specific for highly discriminating ITS sequences. In its multiplex format the assay showed a high specificity, clearly discriminating among different species, as well as a high sensitivity (20 CFU/1 mL sample), making it a potentially useful starting point for the development of a more complete molecular diagnostic assay.
Collapse
Affiliation(s)
- Donata De Marco
- Laboratorio di Microbiologia e Virologia, Diagnostica e Ricerca San Raffaele, Milano.
| | | | | | | | | | | |
Collapse
|
122
|
Mancini N, Perotti M, Ossi CM, Cavallero A, Matuška S, Paganoni G, Burioni R, Rama P, Clementi M. Rapid molecular identification of fungal pathogens in corneal samples from suspected keratomycosis cases. J Med Microbiol 2006; 55:1505-1509. [PMID: 17030909 DOI: 10.1099/jmm.0.46638-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
An increase in the incidence of fungal infections has highlighted the need for rapid and precise detection and identification methods in clinical mycology. This report describes the data obtained on corneal samples from 24 patients with suspected keratomycosis using a conventional cultural approach in parallel with PCR amplification and sequencing of the internal transcribed spacers (ITSs) of the rDNA regions. Using the cultural approach, seven samples (58.3 % of the 12 samples positive for an infectious pathogen) tested positive for a fungal aetiology, with final identification taking a mean time of more than 5 days. In two cases, diagnosis required 10 days. Using the ITS-based molecular approach, a direct diagnosis was obtained in only five of the seven fungus-positive cases (71.4 %) starting from the clinical samples, but identification was still possible in all seven cases within 24 h (by using 16 h cultures for the two remaining cases). Despite the less-than-optimal sensitivity when working directly on clinical samples, the obtained data indicate that the molecular strategy used in this study is a useful complement to the conventional diagnostic approaches used for keratomycosis and, in particular, allows precise and fast fungal identification, in response to the clinical requirements. Similar studies on larger panels of patients and on different clinical samples are required for further investigation of the clinical potential of ITS-based approaches in the diagnosis of mycotic infections.
Collapse
MESH Headings
- Base Sequence
- Cornea/microbiology
- Corneal Diseases/diagnosis
- Corneal Diseases/microbiology
- DNA, Fungal/chemistry
- DNA, Fungal/genetics
- DNA, Ribosomal Spacer/chemistry
- DNA, Ribosomal Spacer/genetics
- Eye Infections, Fungal/diagnosis
- Eye Infections, Fungal/microbiology
- Fungi/genetics
- Fungi/isolation & purification
- Humans
- Molecular Sequence Data
- Polymerase Chain Reaction/methods
- RNA, Ribosomal, 5.8S/chemistry
- RNA, Ribosomal, 5.8S/genetics
- Sequence Alignment
- Sequence Analysis, DNA
Collapse
Affiliation(s)
- Nicasio Mancini
- Università Vita-Salute San Raffaele, Facoltà di Medicina e Chirurgia, Milan, Italy
| | - Mario Perotti
- Università Vita-Salute San Raffaele, Facoltà di Medicina e Chirurgia, Milan, Italy
| | | | | | | | | | - Roberto Burioni
- Università Vita-Salute San Raffaele, Facoltà di Medicina e Chirurgia, Milan, Italy
| | | | - Massimo Clementi
- Università Vita-Salute San Raffaele, Facoltà di Medicina e Chirurgia, Milan, Italy
| |
Collapse
|
123
|
Mancini N, Carletti S, Perotti M, Romanò L, Craxì RDS, Craxì A, Zanetti AR, Clementi M, Burioni R. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment. J Med Virol 2006; 78:1304-11. [PMID: 16927283 DOI: 10.1002/jmv.20704] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
The dynamic features of three specific anti-hepatitis C virus (HCV) antibody subpopulations directed against different conformational epitopes of the viral E2 protein (HCV/E2) have been evaluated in patients with primary and persistent HCV infection; the three subpopulations are present in patients infected with different HCV genotypes and have shown a different activity using a pseudovirus neutralization assay (antibodies e301 and e137 exhibiting high neutralizing activity, while antibody e509 enhancement of HCV infectivity). In sequential samples from five patients with primary HCV infection and different virological outcome, all samples tested negative with the single exception of the e509 antibody in a patient not clearing the virus. In sequential samples from 28 patients with persistent infection under treatment with pegylated interferon-alpha plus ribavirin (14 sustained virological responders and 14 non-responders), the therapy did not selectively influence titers of the two neutralizing antibody subpopulations; otherwise, a net increase of the e509 antibody subpopulation related to enhancement of HCV infectivity was observed in non-responders, but not in sustained virological responders (P = 0.0156). This increase was not related to the trend of total anti-HCV/E2 response. The data indicate that a specific antibody response against these epitopes is elicited only late during the infection, thus not influencing virus clearance during primary infection, and that a selective increase of the antibody subpopulation enhancing virus infectivity is observed only in the cohort of patients not responding to antiviral therapy.
Collapse
Affiliation(s)
- Nicasio Mancini
- Laboratorio di Microbiologia, Università Vita-Salute San Raffaele, Istituto Scientifico San Raffaele, Milano, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
124
|
Mancini N, Perotti M, Carletti S, Canducci F, Sampaolo M, Clementi M, Burioni R. Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient. Mol Immunol 2006; 43:1363-9. [PMID: 16199090 DOI: 10.1016/j.molimm.2005.08.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2005] [Accepted: 08/23/2005] [Indexed: 11/28/2022]
Abstract
A study aiming at cloning and characterizing natural antibodies to human immunodeficiency virus type 1 (HIV-1) targets is described. In particular, we report the molecular cloning of a Fab molecule binding the HIV-1/Tat protein from a seronegative patient. The Fab was characterized for its binding specificity and investigated in regards to its molecular structure. Furthermore, to evaluate the role played by the heavy and light chains in the binding to the antigen, hybrid Fabs were constructed combining the heavy and the light chain of the natural anti-Tat clone with a control high-affinity Fab derived from the repertoire of the same patient. The results indicate that the natural immunoglobulin under study: (i) is a polyreactive antibody of IgG1 isotype, and not an IgM as usually described for anti-HIV natural clones, (ii) shows a pattern of mutations compatible with an antigen-driven mechanisms, (iii) its heavy chain derives from a V-gene subfamily (V3-23) highly represented in fetal life, and (iv) its heavy chain variable region exhibits several characteristics, including an extremely long, hydrophilic CDR3, that are unusual and theoretically important in determining the polyreactive capacity of the molecule.
Collapse
Affiliation(s)
- Nicasio Mancini
- Università Vita-Salute San Raffaele, San Raffaele Diagnostica e Ricerca, IRCCS Istituto Scientifico San Raffaele, Via Olgettina 60, 20132 Milano, Italy
| | | | | | | | | | | | | |
Collapse
|
125
|
Perotti M, Mancini N, Cavallero A, Carletti S, Canducci F, Burioni R, Clementi M. Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction. J Microbiol Methods 2005; 65:632-6. [PMID: 16318892 DOI: 10.1016/j.mimet.2005.10.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2005] [Revised: 10/04/2005] [Accepted: 10/13/2005] [Indexed: 12/27/2022]
Abstract
A real-time PCR assay targeting the highly specific erm34 sequence of Bacillus clausii DNA was developed and optimized. The quantitative assay showed a sensitivity level of 10(2) CFU/microl of sample. The method may represent a useful tool for monitoring the role of B. clausii as probiotic in vivo.
Collapse
Affiliation(s)
- Mario Perotti
- Università Vita-Salute San Raffaele and Laboratorio di Microbiologia e Virologia, Diagnostica e Ricerca San Raffaele, Milan, Italy.
| | | | | | | | | | | | | |
Collapse
|
126
|
Mancini N, Ossi CM, Perotti M, Carletti S, Gianni C, Paganoni G, Matuska S, Guglielminetti M, Cavallero A, Burioni R, Rama P, Clementi M. Direct sequencing of Scedosporium apiospermum DNA in the diagnosis of a case of keratitis. J Med Microbiol 2005; 54:897-900. [PMID: 16091444 DOI: 10.1099/jmm.0.46029-0] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The present report describes the diagnostic strategy followed in a case of keratomycosis. Together with conventional methods, a molecular strategy that involved the direct sequencing of an amplified portion of the genome encompassing the internal transcribed spacer 1 and 2 regions and sequence analysis was used. The data highlight the diagnostic role of molecular techniques, in parallel with conventional methods, in the management of ocular infections of fungal aetiology.
Collapse
Affiliation(s)
- Nicasio Mancini
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Cristina M Ossi
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Mario Perotti
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Silvia Carletti
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Claudia Gianni
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Giorgio Paganoni
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Stanislav Matuska
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Maria Guglielminetti
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Annalisa Cavallero
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Roberto Burioni
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Paolo Rama
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| | - Massimo Clementi
- Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele1 and Centro Malattie della Cornea, Dipartimento di Oftalmologia e Scienze della Visione3, IRCCS Istituto Scientifico San Raffaele, via Olgettina 60, 20132 Milano, Italy 2Università ''Vita-Salute San Raffaele'', Facoltà di Medicina e Chirurgia, Milano, Italy 4Dipartimento di Ecologia del Territorio e degli Ambienti Terrestri, Sezione di Micologia, Università degli Studi di Pavia, Pavia, Italy
| |
Collapse
|
127
|
Mancini N, Ossi CM, Perotti M, Clementi M, DiGiulio DB, Schaenman JM, Montoya JG, McClenny NB, Berry GJ, Mirels LF, Rinaldi MG, Fothergill AW. Molecular mycological diagnosis and correct antimycotic treatments. J Clin Microbiol 2005; 43:3584; author reply 3584-5. [PMID: 16000516 PMCID: PMC1169111 DOI: 10.1128/jcm.43.7.3584-3585.2005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
128
|
Burioni R, Mancini N, Carletti S, Perotti M, Grieco A, Canducci F, Varaldo PE, Clementi M. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection. Virology 2004; 327:242-8. [PMID: 15351212 DOI: 10.1016/j.virol.2004.06.042] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2004] [Revised: 05/17/2004] [Accepted: 06/18/2004] [Indexed: 12/09/2022]
Abstract
Most RNA viruses have evolved mechanisms to avoid neutralizing antibody responses, and it is generally believed that variability of envelope-encoding regions is the major molecular basis of this phenomenon. However, it has been hypothesized that other mechanisms can be involved. Recent experimental data indicate that in hepatitis C virus (HCV) infection, the anti-envelope humoral response includes cross-reactive antibody clones able to neutralize vesicular stomatitis virus (VSV) pseudotypes containing HCV E1 and E2 glycoproteins (HCV/VSV pseudotype) as well as other clones devoid of such activity. In this work, we demonstrate that natural infection with a large variety of HCV isolates belonging to different genotypes elicits HCV/VSV pseudotype-neutralizing cross-reactive anti-envelope antibodies together with clones unable to neutralize this pseudovirus. This was shown by designing a novel strategy for quantitation of serum antibodies binding selectively to single viral cross-reactive conformational epitopes. These data can be useful not only for a better understanding of the virus-host interplay in important viral diseases, but also for the development of an effective anti-HCV vaccine.
Collapse
Affiliation(s)
- Roberto Burioni
- Istituto di Microbiologia, Facoltà di Medicina e Chirurgia, Università di Ancona, 60020 Ancona, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
129
|
Mancini N, Carletti S, Perotti M, Canducci F, Mammarella M, Sampaolo M, Burioni R. Phage display for the production of human monoclonal antibodies against human pathogens. New Microbiol 2004; 27:315-28. [PMID: 15646045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
In the last decade an increasing number of antibodies have made their way from the research benchtops into the clinics and many more are currently under clinical trial. Among monoclonal antibody-producing techniques, phage-display is undoubtedly the most effective and versatile. Cloning of the entire humoral repertoire derived from an infected patients into a phage display vector allows not only the simple generation of monoclonal antibodies of desired specificity, but also the molecular dissection of the antibody response itself. Generation of large panels of human monoclonal antibodies against human pathogens could open new perspectives in understanding the interplay between the infectious agent and the infected host providing tools for the prevention and the therapy of human communicable diseases. In this paper the basic principles of the phage-display approach as well as its most recent applications are reviewed.
Collapse
Affiliation(s)
- N Mancini
- Università "Vita-Salute San Raffaele" IRCCS Istituto Scientifico San Raffaele, Laboratorio di Microbiologia, Diagnostica e Ricerca San Raffaele, Milan, Italy
| | | | | | | | | | | | | |
Collapse
|
130
|
Vicenzi E, Canducci F, Pinna D, Mancini N, Carletti S, Lazzarin A, Bordignon C, Poli G, Clementi M. Coronaviridae and SARS-associated coronavirus strain HSR1. Emerg Infect Dis 2004; 10:413-8. [PMID: 15109406 PMCID: PMC3322807 DOI: 10.3201/eid1003.030683] [Citation(s) in RCA: 113] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
During the recent severe acute respiratory (SARS) outbreak, the etiologic agent was identified as a new coronavirus (CoV). We have isolated a SARS-associated CoV (SARS-CoV) strain by injecting Vero cells with a sputum specimen from an Italian patient affected by a severe pneumonia; the patient traveled from Vietnam to Italy in March 2003. Ultrastructural analysis of infected Vero cells showed the virions within cell vesicles and around the cell membrane. The full-length viral genome sequence was similar to those derived from the Hong-Kong Hotel M isolate. By using both real-time reverse transcription–polymerase chain reaction TaqMan assay and an infectivity plaque assay, we determined that approximately 360 viral genomes were required to generate a PFU. In addition, heparin (100 μg/mL) inhibited infection of Vero cells by 50%. Overall, the molecular and biologic characteristics of the strain HSR1 provide evidence that SARS-CoV forms a fourth genetic coronavirus group with distinct genomic and biologic features.
Collapse
Affiliation(s)
- Elisa Vicenzi
- P2-P3 Laboratories, DIBIT, San Raffaele Scientific Institute, Via Olgettina n. 58, 20132 Milan, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
131
|
Burioni R, Mancini N, Canducci F, Carletti S, Grieco A, Perotti M, Serafini G, Berardinelli E, Bighi S, Varaldo PE, Clementi M. Humoral immune response against hepatitis C virus. J BIOL REG HOMEOS AG 2003; 17:125-7. [PMID: 14518709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
Antibodies are in several instances a reliable marker indicating vigorous immune response against infectious agents and in several viral diseases presence in the blood of specific anti-viral antibodies indicates an effective protection. However, this is not always true. For example, in the case of hepatitis C virus (HCV) an important human pathogen considered the causative agent of the nonA- nonB hepatitis, in spite of an intense antibody response there is no protection against a new infection and in the majority of infected individuals the virus overcomes host defences establishing a persistent infection. Here we describe how the dissection of the humoral immune response against HCV glycoprotein E2 of infected patients was useful for a better comprehension of the virus-host interplay. Cross-reactive antibodies directed against E2 are produced by the HCV-infected patient, but not all of them are protective, and some could even result to be detrimental for the patient. The cross-reactive anti-HCV/E2 humoral antibody response is complex and not necessarily completely beneficial to the host.
Collapse
Affiliation(s)
- R Burioni
- Institute of Microbiology, University of Ancona, Ancona, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
132
|
Mancini N, Canducci F, Carletti S, Berardinelli E, Serafini G, Grieco A, Perotti M, Malcangi G, Danieli MG, Varaldo PE, Clementi M, Burioni R. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. J BIOL REG HOMEOS AG 2003; 17:183-7. [PMID: 14518720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
A complete understanding of the molecular features of humoral immune response could be of pivotal importance in the management of persistent viruses as HCV. In this study, 24 HCV-positive samples, characterized by classical virological parameters, are evaluated using a new assay for the quantitation of antibody subpopulations directed against discrete epitopes on surface glycoprotein E2, a key viral protein. The results, besides confirming the usefulness of this new approach, highlight the extreme heterogeneity of anti-HCV/E2 response as far as single epitopes are concerned. The specific epitopes under study are also demonstrated to be widely shared among different genotypes.
Collapse
Affiliation(s)
- N Mancini
- Institute of Microbiology, University of Ancona, Ancona, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
133
|
Burioni R, Matsuura Y, Mancini N, Tani H, Miyamura T, Varaldo PE, Clementi M. Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype. J Virol 2002; 76:11775-9. [PMID: 12388741 PMCID: PMC136746 DOI: 10.1128/jvi.76.22.11775-11779.2002] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
Hepatitis C virus (HCV) is the major causative agent of blood-borne non-A, non-B hepatitis. Although a strong humoral response is detectable within a few weeks of primary infection and during viral persistence, the role played by antibodies against HCV envelope glycoproteins in controlling viral replication is still unclear. We describe how human monoclonal anti-HCV E2 antibody fragments isolated from a chronically HCV-infected patient differ sharply in their abilities to neutralize infection of HepG2 cells by a vesicular stomatitis virus pseudotype bearing HCV envelope glycoproteins. Two clones were able to neutralize the pseudotype virus at a concentration of 10 micro g/ml, while three other clones completely lacked this activity. These data can explain the lack of protection and the possibility of reinfection that occur even in the presence of a strong antiviral antibody response.
Collapse
Affiliation(s)
- Roberto Burioni
- Institute of Microbiology, University of Ancona, 60020 Ancona, Italy.
| | | | | | | | | | | | | |
Collapse
|
134
|
Burioni R, Bugli F, Mancini N, Fadda G. A novel expression vector for production of epitope-tagged recombinant Fab fragments in bacteria. Hum Antibodies 2002; 10:149-54. [PMID: 11847426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
Labeling of recombinant Fab molecules is an important yet cumbersome and time-consuming procedure that is needed in many immunological experimental designs. This work describes the development of a novel expression vector fusing to the carboxyterminal of the Fab heavy chain fragments a tag peptide (FLAG) that is consistently recognized by a mouse monoclonal antibody. The presence of the FLAG peptide does not alter the binding characteristics of the unmodified Fab molecule, as demonstrated by relative affinity determinations and competition experiments. This new method is suitable for extensive utilization in immunological experimental work using recombinant Fabs.
Collapse
Affiliation(s)
- R Burioni
- Institute of Microbiology, Faculty of Medicine and Surgery, University of Ancona, I-60020 Ancona, Italy.
| | | | | | | |
Collapse
|
135
|
Bugli F, Mancini N, Kang CY, Di Campli C, Grieco A, Manzin A, Gabrielli A, Gasbarrini A, Fadda G, Varaldo PE, Clementi M, Burioni R. Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol 2001; 75:9986-90. [PMID: 11559832 PMCID: PMC114571 DOI: 10.1128/jvi.75.20.9986-9990.2001] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Clinical and experimental evidence indicates that the hepatitis C virus (HCV) E2 glycoprotein (HCV/E2) is the most promising candidate for the development of an effective anti-HCV vaccine. Identification of the human epitopes that are conserved among isolates and are able to elicit protective antibodies would constitute a significant step forward. This work describes the mapping of the B-cell epitopes present on the surface of HCV/E2, as recognized by the immune system during infection, by the analysis of the reciprocal interactions of a panel of human recombinant Fabs derived from an HCV-infected patient. Three unrelated epitopes recognized by antibodies with no neutralization-of-binding (NOB) activity were identified; a fourth, major epitope was defined as a clustering of minor epitopes recognized by Fabs endowed with strong NOB activity.
Collapse
Affiliation(s)
- F Bugli
- Istituti di Microbiologia, Facoltà di Medicina e Chirurgia, Università Cattolica del S. Cuore, 00168 Rome, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
136
|
Burioni R, Bugli F, Mancini N, Rosa D, Di Campli C, Moroncini G, Manzin A, Abrignani S, Varaldo PE, Clementi M, Fadda G. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. Virology 2001; 288:29-35. [PMID: 11543655 DOI: 10.1006/viro.2001.1014] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Evidence from clinical and experimental studies indicates that hepatitis C virus E2 (HCV/E2) glycoprotein is the major target of a putatively protective immune response. However, even in the presence of a vigorous production of anti-HCV/E2 antibodies, reinfection can occur. Dissection of the human immune response against HCV/E2 indicated that blocking of binding of HCV/E2 to target cells [neutralization of binding (NOB) activity] varies widely among antibody clones. Moreover, in vivo, simultaneous binding of antibodies to distinct epitopes can induce conformational changes and synergies that may be relevant to understanding the anti-HCV immune response. In this study, human recombinant Fabs were generated by affinity-selecting a phage display repertoire library with antibody-coated HCV/E2. These Fabs, which share the same complementarity-determining region DNA sequences, had higher affinity than other anti-HCV/E2 Fabs but showed no NOB activity even at the highest concentrations. Binding of Fabs to HCV/E2 caused conformational changes modifying Fab-binding patterns and reducing, with a negative synergistic effect, Fab-mediated NOB activity. These data suggest that some antibody clones have the potential to modify HCV/E2 conformation and that, in this state, binding of this glycoprotein to its cellular target is less prone to inhibition by some antibody clones. This can explain why high anti-HCV/E2 antibody titers do not directly correlate with protection from infection. Information on the interactions among different antibody clones can contribute to understanding virus-host interplay and developing more effective vaccines.
Collapse
Affiliation(s)
- R Burioni
- Institute of Microbiology, Università di Ancona, Ancona, 60020, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|